SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026790
Filing Date
2022-05-16
Accepted
2022-05-16 10:16:07
Documents
31
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_raphaelpharm.htm   iXBRL 10-Q 226536
2 CERTIFICATION f10q0322ex31-1_raphael.htm EX-31.1 9939
3 CERTIFICATION f10q0322ex31-2_raphael.htm EX-31.2 9896
4 CERTIFICATION f10q0322ex32-1_raphael.htm EX-32.1 3268
5 CERTIFICATION f10q0322ex32-2_raphael.htm EX-32.2 3355
  Complete submission text file 0001213900-22-026790.txt   1213862

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cik0000141539-20220331.xsd EX-101.SCH 13393
7 XBRL CALCULATION FILE cik0000141539-20220331_cal.xml EX-101.CAL 12009
8 XBRL DEFINITION FILE cik0000141539-20220331_def.xml EX-101.DEF 62281
9 XBRL LABEL FILE cik0000141539-20220331_lab.xml EX-101.LAB 129978
10 XBRL PRESENTATION FILE cik0000141539-20220331_pre.xml EX-101.PRE 65595
25 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_raphaelpharm_htm.xml XML 62338
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53002 | Film No.: 22926280
SIC: 2833 Medicinal Chemicals & Botanical Products